Sept 16 (Reuters) - Hamilton Thorne Ltd HTL.V
* Hamilton Thorne announces the acquisition of Embryotech Laboratories
* Says transaction is expected to add over US$5 million of revenue and more than us$1.5 million to EBITDA in calendar year 2017
* Expected to increase 2017 EBITDA by over 100%
* Total consideration of approximately us$7.25 million
* Estimates this transaction will be accretive to earnings in 2016 Source text for Eikon: ID:nMKW8kVxla Further company coverage: HTL.V